Abstract
Osteomalacia is a metabolic bone disease that leads to softening of the bones and can be caused by hypophosphatemia. Large clinical studies of low-dose adefovir dipivoxil (adefovir) have found no evidence of renal tubular dysfunction leading to hypophosphatemia after 48 weeks of treatment. We report two cases of low-dose adefovir-induced hypophosphatemic osteomalacia that initially presented with diffuse musculoskeletal pain. The first patient was a 62-year-old man with a 2-year history of bone pain involving the dorsal mid-thorax, lower anterior chest wall, right sacroiliac joint area, and both knees. The patient had been receiving adefovir for 5 years before confirmation of hypophosphatemia and urinary phosphate wasting. Bone scintigraphy revealed multifocal lesions including multiple ribs, costochondral junctions, costovertebral junctions, sacrum, both posterior iliac bones, both proximal tibia, right calcaneus, and the left second metatarsophalangeal joint area, which were suggestive of metabolic bone disorder. Bone pain was significantly reduced within 3 months after supplementation with phosphate and calcitriol. The second patient was a 54-year-old male who presented with an 18-month history of severe bone pain of the right medial knee and low back. The patient had been taking adefovir for approximately 40 months before the development of bone pain. Laboratory data revealed hypophosphatemia and vitamin D deficiency. Bone scintigraphy showed increased uptake in bilateral ribs, sternum, both scapulae, both costovertebral junctions, both pelvic bones, medial cortex of the right proximal femur, right proximal tibia, and the left lateral tarsal bone. The symptoms improved by changing the antiviral agent from adefovir to entecavir. Because osteomalacia often presents with diffuse bone pain, non-specific radiologic findings and non-characteristic routine serum biochemical changes, the disease can be confused with various musculoskeletal diseases and a high index of suspicion is necessary for an early diagnosis in patients receiving adefovir therapy.
Similar content being viewed by others
References
Minemura M, Tokimitsu Y, Tajiri K, Nakayama Y, Kawai K, Kudo H, Hirano K, Atarashi Y, Yata Y, Yasumura S, Takahara T, Sugiyama T (2010) Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil. World J Hepatol 2:442–446
Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, Chen RC, Seibel MJ (2011) Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol 45:468–473
Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D’Agati VD (2001) Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 32:734–740
Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, Brosgart CL, Westland C, Arterbrun S, Deray G (2004) Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int 66:1153–1158
Fabbriciani G, de Socio GV, Massarotti M, Ceriani R, Marasini B (2011) Adefovir induced hypophosphatemic osteomalacia. Scand J Infect Dis 43:990–992
Carpenter TO (2012) The expanding family of hypophosphatemic syndromes. J Bone Miner Metab 30:1–9
Gifre L, Peris P, Monegal A, Martinez de Osaba MJ, Alvarez L, Guanabens N (2011) Osteomalacia revisited: a report on 28 cases. Clin Rheumatol 30:639–645
Reginato AJ, Coquia JA (2003) Musculoskeletal manifestations of osteomalacia and rickets. Best Pract Res Clin Rheumatol 17:1063–1080
Kwon SY, Ahn SY, Ko SY, Jang YM, Choi YH, Kim BK, Choe WH, Lee CH (2010) A case of osteomalacia related to adefovir in a patient with chronic hepatitis B. Korean J Gastroenterol 56:117–120
Lee HJ, Choi JW, Kim TN, Eun JR (2008) A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus. Korean J Hepatol 14:381–386
Earle KE, Seneviratne T, Shaker J, Shoback D (2004) Fanconi’s syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res 19:714–721
Izzedine H, Kheder-Elfekih R, Housset P, Sarkozy C, Brocheriou I, Deray G (2009) Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient. AIDS 23:544–545
Jung YK, Yeon JE, Choi JH, Kim CH, Jung ES, Kim JH, Park JJ, Kim JS, Bak YT, Byun KS (2010) Fanconi’s syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient. Gut Liver 4:389–393
Kawate H, Taketomi A, Watanabe T, Nomura M, Kato M, Sakamoto R, Ikegami T, Soejima Y, Maehara Y, Takayanagi R (2011) Hypophosphatemic osteomalacia as a long-term complication after liver transplantation. Transplantation 91:e6–e8
Wong T, Girgis CM, Ngu MC, Chen RC, Emmett L, Archer KA, Seibel MJ (2010) Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab 95:479–480
Reginato AJ, Falasca GF, Pappu R, McKnight B, Agha A (1999) Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review. Semin Arthritis Rheum 28:287–304
Luxon BA (2011) Bone disorders in chronic liver diseases. Curr Gastroenterol Rep 13:40–48
Berry JL, Davies M, Mee AP (2002) Vitamin D metabolism, rickets, and osteomalacia. Semin Musculoskelet Radiol 6:173–182
Fogelman I, McKillop JH, Bessent RG, Boyle IT, Turner JG, Greig WR (1978) The role of bone scanning in osteomalacia. J Nucl Med 19:245–248
Hain SF, Fogelman I (2002) Nuclear medicine studies in metabolic bone disease. Semin Musculoskelet Radiol 6:323–329
Conflict of interest
All authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kim, D.H., Sung, D.H. & Min, Y.K. Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. J Bone Miner Metab 31, 240–246 (2013). https://doi.org/10.1007/s00774-012-0384-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-012-0384-y